Cancer Treatment

June 17, 2026
Virginia Cancer Specialists: 21 Doctors in Top Docs Hall of Fame
FAIRFAX, June 17 — Virginia Cancer Specialists announced that 21 of its physicians have been named to the Washingtonian “Top Doctors” Hall…
June 9, 2026
Johann Lafer’s Lymph Nodes Shrink After Four Chemotherapy Cycles
HAMBURG — The lymph nodes are shrinking. For Johann Lafer, that is the difference between a treatment that is working and one…
June 9, 2026
Johann Lafer’s Lymphoma Treatment Yields Promising Early Results Already
Understanding Lafer’s Condition Lafer was diagnosed with an indolent, low-grade, non-Hodgkin lymphoma earlier this year, with the diagnosis being made public in…
June 9, 2026
Roche Launches 7-Minute Lung Cancer Injection to Replace Hour-Long IV Drips
For lung cancer patients in India, the treatment chair has been a fixed point — hours of intravenous drip, hospital waits, repeated…
June 9, 2026
Roche Launches 7-Minute Lung Cancer Shot in India, Replacing Hour-Long IV
MUMBAI — For lung cancer patients in India, a treatment that once meant sitting for an hour or more with an IV…
June 9, 2026
Roche Launches Subcutaneous Lung Cancer Immunotherapy in India
MUMBAI — The needle goes in. Seven minutes later, it’s over. That is the new reality for lung cancer patients in India,…
June 9, 2026
7-Minute Injection To Treat Lung Cancer Comes To India
MUMBAI, June 9, 2026 — infopulsetoday.com — Roche Pharma India has announced the launch of Tecentriq® (atezolizumab) SC in India, the country’s…
September 18, 2025
Keytruda Cancer Drug Shows Promising Results Despite Side Effects
Patients receiving pembrolizumab, the immunotherapy drug sold as Keytruda, commonly report a range of side effects including fatigue, musculoskeletal pain, diarrhea, nausea,…
December 20, 2024
Nivolumab/hyaluronidase approved in US for cancer treatment
United States, December 20, 2024 — infopulsetoday.com — Nivolumab/hyaluronidase, a newly approved anti-cancer medication, has been cleared for medical use in the…
September 16, 2024
Pfizer Drug Ponsegromab Boosts Weight in Cachexia Trial
Cancer patients losing dangerous amounts of weight have long had few medical options. A monoclonal antibody called ponsegromab might change that. Pfizer…
August 18, 2024
FDA Approves Lazertinib for Lung Cancer Patients
For patients with a common form of lung cancer, a new treatment option arrived in the United States on August 15, 2024.…
August 18, 2024
New Lung Cancer Treatment Option Arrives in United States Market
On August 15, 2024, the United States Food and Drug Administration authorized the use of Lazertinib for patients diagnosed with non-small cell…
June 20, 2024
FDA Approves Imetelstat for Myelodysplastic Syndromes
June 20, 2024 — cyberinktimes.com — The FDA approved a new cancer drug on June 15, 2024. It works by attacking the…
August 16, 2023
New Drug Forces Immune Cells to Attack Multiple Myeloma
August 15, 2023, brought a significant shift for multiple myeloma patients who had exhausted existing therapies. On that date, regulatory authorities in…
August 15, 2023
Experimental Medication AOH1996 Enters Phase I Cancer Treatment Trials
An investigational cancer medication called AOH1996 has entered Phase I clinical trials at City of Hope as of August 15, 2023, marking…
August 15, 2023
City of Hope drug targets cancer-specific protein, spares healthy cells
/ HTML. 450-560 words. Must not invent quotes etc. Use only facts from source. Let’s list facts: – DNA repair mechanics frustrated…
December 16, 2022
FDA Approves Pluvicto for Advanced Prostate Cancer Treatment
A radiopharmaceutical known as Lutetium (177Lu) vipivotide tetraxetan has become available for patients with a specific form of advanced prostate cancer following…
November 17, 2022
FDA Approves New Cancer Treatment With Unique Mechanism Action
The U.S. Food and Drug Administration granted approval on November 15, 2022, to Mirvetuximab soravtansine, a new medication marketed as Elahere, for…